Office of infectious disease and HIV/aids policy (OIDP): ending the HIV epidemic - pre-exposure prophylaxis (PREP) implementation and dissemination services
Ended Definitive Contract Awarded Last action
- Contract number
- 75P00119C00080
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $1,402,138
Award facts
- Opportunity
- Contract value 41% obligated
-
- $1,402,137.99 Current, with exercised options
- $3,461,637.99 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Foster City, CA 94404, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$4,390,432 | |
| Other Administrative Action | -$5,117,930 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $148,000 | |
| Exercise an Option | $4,747,250 | |
| Original award | $6,015,250 |
About this award
This is a $3,461,637.99 firm fixed price definitive contract awarded by the Office of Infectious Disease and HIV/AIDS Policy (OIDP) to Gilead Sciences Inc. for Ending the HIV Epidemic - Pre-Exposure Prophylaxis (PrEP) Implementation and Dissemination Services. The contract was awarded on September 30, 2019 and has an ultimate completion date of October 29, 2020. Gilead Sciences Inc. is a large biopharmaceutical company that specializes in developing and commercializing innovative pharmaceutical products, including antiviral medications, cancer immunotherapies, and drugs for complex medical conditions. The contract is not set aside for small businesses. Gilead has a significant Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs (VA) National Acquisition Center, valued at $29,160,000.00 and running through October 31, 2025, which covers the procurement of specialized pharmaceutical products including HIV treatments. This contract and BPA underscore Gilead's strategic importance as a supplier of advanced medical treatments to federal healthcare programs.
Quick answers
Who was awarded contract 75P00119C00080?
75P00119C00080 was awarded to Gilead Sciences Inc. by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on September 30, 2019.
How much is contract 75P00119C00080 worth?
The government has obligated $1,402,138 on 75P00119C00080. Its potential value, with all options, is $3,461,638.
Was contract 75P00119C00080 competed?
The extent of competition for 75P00119C00080 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award